Literature DB >> 16645216

Detection of common disease-causing mutations in mitochondrial DNA (mitochondrial encephalomyopathy, lactic acidosis with stroke-like episodes MTTL1 3243 A>G and myoclonic epilepsy associated with ragged-red fibers MTTK 8344A>G) by real-time polymerase chain reaction.

Hongxin Fan1, Chris Civalier, Jessica K Booker, Margaret L Gulley, Thomas W Prior, Rosann A Farber.   

Abstract

The 3243A>G mutation in the MTTL1 (tRNA(Leu)) gene and the 8344A>G mutation in the MTTK (tRNA(Lys)) gene are the most common mutations found in mitochondrial encephalomyopathy, lactic acidosis with stroke-like episodes and myoclonic epilepsy associated with ragged-red fibers, respectively. These mitochondrial DNA mutations are usually detected by conventional polymerase chain reaction followed by restriction enzyme digestion and gel electrophoresis. We developed a LightCycler real-time polymerase chain reaction assay to detect these two mutations based on fluorescence resonance energy transfer technology and melting curve analysis. Primers and fluorescence-labeled hybridization probes were designed so that the sensor probe spans the mutation site. The observed melting temperatures differed in the mutant and wild-type DNA by 9 degrees C for the MTTL1 gene and 6 degrees C for the MTTK gene. This method correctly identified all 10 samples that were 3243A>G mutation-positive, all 4 samples that were 8344A>G mutation-positive, and all 30 samples that were negative for both mutations, as previously identified by traditional gel-based methods. This LightCycler assay is a rapid and reliable technique for molecular diagnosis of these mitochondrial gene mutations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16645216      PMCID: PMC1867587          DOI: 10.2353/jmoldx.2006.050066

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  12 in total

Review 1.  Mutation detection using fluorescent hybridization probes and melting curve analysis.

Authors:  E Lyon
Journal:  Expert Rev Mol Diagn       Date:  2001-05       Impact factor: 5.225

2.  Oxidative capacity correlates with muscle mutation load in mitochondrial myopathy.

Authors:  Tina D Jeppesen; Marianne Schwartz; David B Olsen; John Vissing
Journal:  Ann Neurol       Date:  2003-07       Impact factor: 10.422

3.  Simultaneous A8344G heteroplasmy and mitochondrial DNA copy number quantification in myoclonus epilepsy and ragged-red fibers (MERRF) syndrome by a multiplex molecular beacon based real-time fluorescence PCR.

Authors:  K Szuhai; J Ouweland; R Dirks; M Lemaître; J Truffert; G Janssen; H Tanke; E Holme; J Maassen; A Raap
Journal:  Nucleic Acids Res       Date:  2001-02-01       Impact factor: 16.971

4.  Mutation screening of the mitochondrial genome using denaturing high-performance liquid chromatography.

Authors:  Andrew Biggin; Robert Henke; Bruce Bennetts; David R Thorburn; John Christodoulou
Journal:  Mol Genet Metab       Date:  2004-11-11       Impact factor: 4.797

5.  Widespread tissue distribution of a tRNALeu(UUR) mutation in the mitochondrial DNA of a patient with MELAS syndrome.

Authors:  E Ciafaloni; E Ricci; S Servidei; S Shanske; G Silvestri; G Manfredi; E A Schon; S DiMauro
Journal:  Neurology       Date:  1991-10       Impact factor: 9.910

6.  Rapid detection of the A----G(8344) mutation of mtDNA in Italian families with myoclonus epilepsy and ragged-red fibers (MERRF).

Authors:  M Zeviani; P Amati; N Bresolin; C Antozzi; G Piccolo; A Toscano; S DiDonato
Journal:  Am J Hum Genet       Date:  1991-02       Impact factor: 11.025

7.  The LightCycler: a microvolume multisample fluorimeter with rapid temperature control.

Authors:  C T Wittwer; K M Ririe; R V Andrew; D A David; R A Gundry; U J Balis
Journal:  Biotechniques       Date:  1997-01       Impact factor: 1.993

8.  Quantitation of heteroplasmy in mitochondrial DNA mutations by primer extension using Vent(R)(exo-) DNA polymerase and RFLP analysis.

Authors:  F K Jacobi; J Meyer; C M Pusch; B Wissinger
Journal:  Mutat Res       Date:  2001-07-01       Impact factor: 2.433

9.  Detection and quantification of heteroplasmic mutant mitochondrial DNA by real-time amplification refractory mutation system quantitative PCR analysis: a single-step approach.

Authors:  Ren-Kui Bai; Lee-Jun C Wong
Journal:  Clin Chem       Date:  2004-04-08       Impact factor: 8.327

Review 10.  Techniques and pitfalls in the detection of pathogenic mitochondrial DNA mutations.

Authors:  Carlos T Moraes; David P Atencio; Jose Oca-Cossio; Francisca Diaz
Journal:  J Mol Diagn       Date:  2003-11       Impact factor: 5.568

View more
  4 in total

Review 1.  Physiology and pathophysiology of mitochondrial DNA.

Authors:  Hongzhi Li; Danhui Liu; Jianxin Lu; Yidong Bai
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

2.  Mitochondrial variants in schizophrenia, bipolar disorder, and major depressive disorder.

Authors:  Brandi Rollins; Maureen V Martin; P Adolfo Sequeira; Emily A Moon; Ling Z Morgan; Stanley J Watson; Alan Schatzberg; Huda Akil; Richard M Myers; Edward G Jones; Douglas C Wallace; William E Bunney; Marquis P Vawter
Journal:  PLoS One       Date:  2009-03-17       Impact factor: 3.240

3.  The role of mitochondrial DNA damage and repair in the resistance of BCR/ABL-expressing cells to tyrosine kinase inhibitors.

Authors:  Sylwester Glowacki; Ewelina Synowiec; Janusz Blasiak
Journal:  Int J Mol Sci       Date:  2013-08-07       Impact factor: 5.923

4.  Whole Exome Sequencing Is the Preferred Strategy to Identify the Genetic Defect in Patients With a Probable or Possible Mitochondrial Cause.

Authors:  Tom E J Theunissen; Minh Nguyen; Rick Kamps; Alexandra T Hendrickx; Suzanne C E H Sallevelt; Ralph W H Gottschalk; Chantal M Calis; Alphons P M Stassen; Bart de Koning; Elvira N M Mulder-Den Hartog; Kees Schoonderwoerd; Sabine A Fuchs; Yvonne Hilhorst-Hofstee; Marianne de Visser; Jo Vanoevelen; Radek Szklarczyk; Mike Gerards; Irenaeus F M de Coo; Debby M E I Hellebrekers; Hubert J M Smeets
Journal:  Front Genet       Date:  2018-10-12       Impact factor: 4.599

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.